Aclarion, Inc. (ACON)
$0.00+$0.00 (+0.00%) Latest sessionExtended Hours
Gregory A. Gould - Officer
Ryan Bond - Director
Brent Ness - OfficerAclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 6 | 51,863 | $126K |
21 Form 4 filings on record, the earliest from Sep 2, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Amanda Mae Sequira - Director | Open-market purchase | Common Stock | 5,857 | $2.73 | $16K | |
| Gregory A. Gould - Officer | Open-market purchase | Common Stock | 10,000 | $2.45 | $25K | |
| Ryan Bond - Director | Open-market purchase | Common Stock | 21,122 | $2.37 | $50K | |
| William Wesemann - Director | Open-market purchase | Common Stock | 2,150 | $2.34 | $5K | |
| David K. Neal - Director | Open-market purchase | Common Stock | 7,500 | $2.40 | $18K | |
| Brent Ness - Officer | Open-market purchase | Common Stock | 5,234 | $2.31 | $12K | |
| Ryan Bond - Officer | Grant or award | Common Stock | 55,000 | $0.00 | - | |
| Amanda Mae Sequira - Director | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Scott Breidbart - Director | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Gregory A. Gould - Officer | Grant or award | Common Stock | 50,000 | $0.00 | - | |
| Brent Ness - Officer | Grant or award | Common Stock | 100,000 | $0.00 | - | |
| William Wesemann - Director | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Jeffrey John Thramann - Officer | Grant or award | Common Stock | 100,000 | $0.00 | - | |
| David K. Neal - Director | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Stephen Deitsch - Director | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Scott Breidbart - Director | Open-market purchase | Common Stock | 5,664 | $3.18 | $18K | |
| David K. Neal - Director | Open-market purchase | Common Stock | 2,500 | $3.10 | $8K | |
| Brent Ness - Officer | Open-market purchase | Common Stock | 6,289 | $3.18 | $20K | |
| William Wesemann - Director | Open-market purchase | Common Stock | 1,562 | $3.30 | $5K | |
| Brent Ness - Officer | Open-market purchase | Common Stock | 10 | $6.20 | $62 | |
| Gregory A. Gould - Officer | Grant or award | Stock Option (right to buy) | 17,000 | $0.00 | - |
Aclarion, Inc. (ACON) had 6 insider filings in the last 90 days, with the most recent on 2026-08-19. The full record for ACON runs to 21 Form 4 filings, the earliest from 2025-09-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
6 insider purchases of ACON were filed in the last 90 days, totaling $126K.
No insider sales of ACON were filed in the last 90 days.
This page tracks ACON Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add ACON to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
